Vyvanse Generics Roll Out — And Disappoint

As the U.S. patent for Vyvanse expired August 2023, the FDA cleared 14  manufacturers to produce Vyvanse generics.  It might take several months for a significant number of consumers to access these Vyvanse generics. At …

Vyvanse Generics Roll Out — And Disappoint Read More »

The post Vyvanse Generics Roll Out — And Disappoint appeared first on ADHD Roller Coaster — Gina Pera.